{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:28Z","timestamp":1791924208516,"version":"4.3.4"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1093\/ckj\/sfy137","type":"journal-article","created":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T09:21:13Z","timestamp":1545384073000},"page":"216-223","source":"Crossref","is-referenced-by-count":25,"title":["Risk of relapse of multiple myeloma following kidney transplantation"],"prefix":"10.1093","volume":"12","author":[{"given":"Sapna","family":"Shah","sequence":"first","affiliation":[{"name":"King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Delaney","sequence":"additional","affiliation":[{"name":"East Kent Hospital University NHS Foundation Trust, Kent, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Schey","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceri","family":"Bygrave","sequence":"additional","affiliation":[{"name":"Cardiff and Vale University Health Board, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Streetly","sequence":"additional","affiliation":[{"name":"Guy\u2019s and St Thomas\u2019 NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Benjamin","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital NHS Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,25]]},"reference":[{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B1","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3727\/096368915X688560","article-title":"Hematopoietic cell and renal transplantation in plasma cell dyscrasia patients","volume":"25","author":"Baraldi","year":"2015","journal-title":"Cell Trans"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B2","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjh.14328","article-title":"Characteristics and outcomes of patients with multiple myeloma aged 21\u201340 years versus 41\u201360 years: a multi-institutional case-control study","volume":"175","author":"Jurczyszyn","year":"2016","journal-title":"Br J Haematol"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B3","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","article-title":"Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002 - Medical Research Council Adult Leukaemia Working Party","volume":"23","author":"Augustson","year":"2005","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B4","first-page":"207","article-title":"Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival","volume":"56","author":"Abbott","year":"2001","journal-title":"Clin Nephrol"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B5","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/ndt\/gfp679","article-title":"Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study","volume":"25","author":"Tsakiris","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B6","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1681\/ASN.2006020139","article-title":"Multiple myeloma","volume":"17","author":"Korbet","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B7","first-page":"154","article-title":"Reversal of acute renal impairment by bortezomib-doxorubicin-dexamethasone in multiple myeloma. Results from a phase II study","volume":"94 (Suppl)","author":"Ludwig","year":"2009","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1600-0609.2004.00272.x","article-title":"Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure","volume":"73","author":"Tosi","year":"2004","journal-title":"Eur J Haematol"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B9","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1016\/j.clml.2015.07.373","article-title":"Retrospective analysis of the impact of kidney function on the outcomes of first autografts for de novo myeloma patients in the era of novel agents","volume":"15","author":"Floro","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B10","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1097\/TXD.0000000000000716","article-title":"Kidney transplantation in patients with active multiple myeloma: case reports","volume":"3","author":"Lum","year":"2017","journal-title":"Transplant Direct"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B11","year":"2012"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2013.247","article-title":"IMWG consensus on risk stratification in multiple myeloma","volume":"28","author":"Chng","year":"2014","journal-title":"Leukemia"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/ajt.14625","article-title":"The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials","volume":"18","author":"Haas","year":"2018","journal-title":"Am J Transplant"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/bmt.2008.179","article-title":"High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease","volume":"42","author":"Hassoun","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/nep.12116","article-title":"Renal transplant in plasma cell dyscrasias with lenalidomide treatment after autologous stem cell transplantation","volume":"18","author":"S\u00e1nchez Quintana","year":"2013","journal-title":"Nephrology"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1053\/j.ajkd.2016.12.023","article-title":"Kidney transplantation for kidney failure due to multiple myeloma: case reports","volume":"69","author":"Le","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B17","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1053\/j.ajkd.2016.11.024","article-title":"Acute kidney allograft rejection precipitated by lenalidomide treatment for multiple myeloma","volume":"69","author":"Lum","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B18","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.transproceed.2018.01.014","article-title":"Severe renal allograft rejection resulting from lenalidomide therapy for multiple myeloma: case report","volume":"50","author":"Walavalkar","year":"2018","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.transproceed.2015.04.056","article-title":"Evaluation of infectious complications in the first year after kidney transplantation","volume":"47","author":"Yalci","year":"2015","journal-title":"Transplant Proc"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B20","first-page":"1","article-title":"European Best Practice Guidelines for Renal Transplantation (Part 1)","volume":"15 (Suppl 7)","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t2019040804011116000_sfy137-B21","doi-asserted-by":"crossref","first-page":"c228","DOI":"10.1159\/000341760","article-title":"Defining the role of renal transplantation in the modern management of multiple myeloma and other plasma cell dyscrasias","volume":"120","author":"Bansal","year":"2012","journal-title":"Nephron Clin Pract"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ckj\/article-pdf\/12\/2\/216\/28283621\/sfy137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:58:45Z","timestamp":1781017125000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/12\/2\/216\/5301496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,25]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,1,25]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfy137","relation":{},"ISSN":["2048-8513"],"issn-type":[{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2019,1,25]]}}}